stockrowMesoblast Limited (MESO) vs First Tracks Biotherapeutics, Inc. (TRAX)
- Mesoblast Limited MESO 14.23 +0.92%
- First Tracks Biotherapeutics, Inc. TRAX 47.78 +5.17%
Mesoblast Limited and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Mesoblast Limited and First Tracks Biotherapeutics, Inc. are of similar size ($1.9B and $1.8B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −1,091.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, First Tracks Biotherapeutics, Inc. leads on 5 and Mesoblast Limited on 2.
Valuation
Profitability
| Metric | MESO | TRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | — | 68.51% |
| Operating margin | (826.28%) | 0.00% | 0.00% |
| Net margin | (1,091.71%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (51.96%) |
| Return on assets | 0.00% | 0.00% | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack